Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis.

Nick BansbackJudy A ChiuRebecca MetcalfeEmmanuelle Lapointe Alice SchabasMarilyn LenzenAnthony TraboulseeLarry D LyndRobert Carruthers

Published in: Multiple sclerosis journal - experimental, translational and clinical (2021)

This pilot study suggests that PtDA use helps RRMS patients and their clinician select a DMT. Future studies will assess the feasibility of implementation and the impact of the PtDA on timely DMT initiation and longer-term adherence.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
newly diagnosed
white matter
healthcare
primary care
chronic kidney disease
peritoneal dialysis
preterm infants
metabolic syndrome
adipose tissue
gestational age
rheumatoid arthritis
insulin resistance